je.st
news
a Recro buys pain medicine, manufacturing plant in a potential $170M deal
2015-03-09 15:38:08| Biotech - Topix.net
Recro Pharma Inc. signed a definitive agreement Monday to acquire the rights to an experimental pain medicine and a contract manufacturing facility from Alkermes in a deal valued at up to $170 million. Under the terms of the agreement, Recro Pharma of Malvern, Pa., will make an upfront payment of $50 million to Alkermes .
Tags: potential
deal
medicine
manufacturing
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||